
    
      This study has three specific aims:

        1. to create a Midazolam PBPK model based on anthropometric and physiopathological data
           from enrolled patients;

        2. to estimate cerebral and systemic Midazolam concentrations;

        3. to assess independent variables about Midazolam pharmacokinetic in critically ill
           patients.
    
  